539871 Stock Overview
Provides diagnostic testing services to patients, laboratories, and hospitals in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 5/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Thyrocare Technologies Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹957.45 |
| 52 Week High | ₹1,002.00 |
| 52 Week Low | ₹552.10 |
| Beta | 0.44 |
| 11 Month Change | 5.41% |
| 3 Month Change | 6.58% |
| 1 Year Change | 68.28% |
| 33 Year Change | -12.88% |
| 5 Year Change | 74.34% |
| Change since IPO | 54.93% |
Recent News & Updates
Recent updates
Shareholder Returns
| 539871 | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | -1.9% | 0.4% | -1.2% |
| 1Y | 68.3% | 37.9% | 25.5% |
Return vs Industry: 539871 exceeded the Indian Healthcare industry which returned 37.9% over the past year.
Return vs Market: 539871 exceeded the Indian Market which returned 25.5% over the past year.
Price Volatility
| 539871 volatility | |
|---|---|
| 539871 Average Weekly Movement | 4.5% |
| Healthcare Industry Average Movement | 5.5% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 539871 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 539871's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 1,693 | Rahul Guha | www.thyrocare.com |
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, and various infectious diseases.
Thyrocare Technologies Limited Fundamentals Summary
| 539871 fundamental statistics | |
|---|---|
| Market cap | ₹50.70b |
| Earnings (TTM) | ₹839.60m |
| Revenue (TTM) | ₹6.23b |
60.4x
P/E Ratio8.1x
P/S RatioIs 539871 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 539871 income statement (TTM) | |
|---|---|
| Revenue | ₹6.23b |
| Cost of Revenue | ₹3.14b |
| Gross Profit | ₹3.09b |
| Other Expenses | ₹2.25b |
| Earnings | ₹839.60m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 15.86 |
| Gross Margin | 49.55% |
| Net Profit Margin | 13.47% |
| Debt/Equity Ratio | 0.02% |
How did 539871 perform over the long term?
See historical performance and comparison